Received Apr 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | 1 | UK232AB | IM / RL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | GP759 | IM / LL |
The patient recevied a Pentacel vaccination as opposed to Daptacel. The patient suffered no adverse effects and can continue on their regular vaccination schedule.